Your browser doesn't support javascript.
loading
Intra-oral Acantholytic Squamous Cell Carcinoma: 55 Cases. Is this Variant more Aggressive?
Abba, Michael; Kaplan, Ilana; Livoff, Alejandro; Zagury, Amram; Nahlieli, Oded; Vered, Marilena; Nazarova, Nigora; Allon, Irit.
Afiliación
  • Abba M; Department of Oral & Maxillofacial Surgery, Barzilai Medical Center, Ashkelon, Israel. drabba@me.com.
  • Kaplan I; Institute of Pathology, Rabin Medical Center, Petach-Tiqva, Israel.
  • Livoff A; Institute of Pathology, Sourasky Medical Center, Tel-Aviv, Israel.
  • Zagury A; Department of Oral Pathology & Oral Medicine, School of Dental Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Nahlieli O; Institute of Pathology, Barzilai Medical Center, Ashkelon, Israel.
  • Vered M; Department of Oral & Maxillofacial Surgery, Barzilai Medical Center, Ashkelon, Israel.
  • Nazarova N; Department of Oral & Maxillofacial Surgery, Barzilai Medical Center, Ashkelon, Israel.
  • Allon I; School of Health Sciences, Ben Gurion University, Beer Sheva, Israel.
Head Neck Pathol ; 16(2): 388-393, 2022 Jun.
Article en En | MEDLINE | ID: mdl-34378166
ABSTRACT
We aimed to collect and analyze available cases of intraoral acantholytic squamous cell carcinoma (aSCC), that consisted of the authors' cases and cases derived from the existing literature, with an emphasis on the pathological staging and patient outcome. Our research question was whether aSCC is more aggressive than conventional SCC. The literature was searched for documented cases of aSCC involving the intra-oral mucosa, excluding those from the lips and tonsils, and seven new cases were added from our files. The authors compared the obtained aSCC data to existing data for conventional SCC. Fisher Exact or Pearson's χ2 tests were used for categorical variables. Fifty-five cases of intraoral aSCC were reviewed, of which 48 were retrieved from the literature. Analysis of the published cases was reinforced by contacting the authors of all the papers with incomplete data for further clarifications. The most common sites of aSCC were the tongue (24/55) and the maxilla/maxillary gingiva and/or palate (11/55). The overall survival rate was 36/53 (67.9%) with a mean follow-up period of 22 months against 62.5% for conventional SCC (p = 0.6). No statistically significant difference between the two variants of the tumor with respect to the oral cavity was detected. The differences in age, sex, survival rate, staging, and locations were not statistically significant. Based on the available data from 55 cases, there is no evidence to suggest that aSCC is more aggressive than conventional SCC in intraoral cases.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article